AAAAAA
Results:
1-15
|
Results: 15
Authors:
IVERSEN N
LINDAHL AK
ABILDGAARD U
Citation: N. Iversen et al., ELEVATED TFPI IN MALIGNANT DISEASE - RELATION TO CANCER TYPE AND HYPERCOAGULATION, British Journal of Haematology, 102(4), 1998, pp. 889-895
Authors:
LINDAHL AK
Citation: Ak. Lindahl, TISSUE FACTOR PATHWAY INHIBITOR - FROM UNKNOWN COAGULATION INHIBITOR TO MAJOR ANTITHROMBOTIC PRINCIPLE, Cardiovascular Research, 33(2), 1997, pp. 286-291
Authors:
ROALD OK
LINDAHL AK
SCHONDORF C
KROESE A
ABILDGAARD U
Citation: Ok. Roald et al., REDUCED RATE OF COMPLICATIONS WITH AUTOTRANSFUSION OF WASHED BLOOD ASCOMPARED TO UNWASHED BLOOD DURING SURGERY FOR ABDOMINAL AORTIC-ANEURYSMS, Circulation, 94(8), 1996, pp. 1373-1373
Authors:
LINDAHL AK
Citation: Ak. Lindahl, TISSUE FACTOR PATHWAY INHIBITOR IN HEALTH AND DISEASE, Trends in cardiovascular medicine, 5(4), 1995, pp. 167-171
Authors:
LINDAHL AK
SANDSET PM
THUNEWIIGER M
NORDFANG O
SAKARIASSEN KS
Citation: Ak. Lindahl et al., TISSUE FACTOR PATHWAY INHIBITOR PREVENTS THROMBUS FORMATION ON PROCOAGULANT SUBENDOTHELIAL MATRIX, Blood coagulation & fibrinolysis, 5(5), 1994, pp. 755-760
Authors:
BOFFA MC
LAPEYRERE C
BERARD M
LINDAHL AK
FLAGEUL B
CHEMALY P
ABILDGAARD U
DUBERTRET L
Citation: Mc. Boffa et al., PLASMA THROMBOMODULIN LEVEL IN MALIGNANCY VARIES ACCORDING TO THE TUMOR TYPE, Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000087-190000088
Authors:
HANSON SR
MARKOU C
LINDAHL AK
KU DN
SCARBOROUGH RM
PHILLIPS DR
GORECKI M
PINET A
GARFINKEL L
KELLY AB
HARKER LA
Citation: Sr. Hanson et al., INHIBITION OF IN-VIVO THROMBUS FORMATION IN AN ARTERIAL-STENOSIS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 540-540
Authors:
IVERSEN N
LINDAHL AK
KVALOY S
ABILDGAARD U
Citation: N. Iversen et al., HIGH-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PLASMA FROM MANY PATIENTS WITH SOLID TUMORS CONTRAST WITH FINDINGS IN LYMPHOMA PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 602-602
Authors:
LINDAHL AK
MORSER J
GLASER CB
HARKER LA
HANSON SR
Citation: Ak. Lindahl et al., INFUSION OF RECOMBINANT THROMBOMODULIN INHIBITS THROMBUS FORMATION INBABOONS, Thrombosis and haemostasis, 69(6), 1993, pp. 737-737
Authors:
LINDAHL AK
NORDFANG O
WILDGOOSE P
KELLY AB
HARKER LA
HANSON SR
Citation: Ak. Lindahl et al., ANTITHROMBOTIC EFFECTS OF A TRUNCATED TISSUE FACTOR PATHWAY INHIBITOR(TFPI) IN BABOONS, Thrombosis and haemostasis, 69(6), 1993, pp. 742-742
Authors:
LINDAHL AK
SANDSET PM
NORDFANG O
SAKARIASSEN KS
Citation: Ak. Lindahl et al., TISSUE FACTOR PATHWAY INHIBITOR PREVENTS FIBRIN DEPOSITION ON PROCOAGULANT SUBENDOTHELIAL MATRIX WHEN EXPOSED TO FLOWING NONANTICOAGULATED HUMAN BLOOD, Thrombosis and haemostasis, 69(6), 1993, pp. 972-972
Authors:
LINDAHL AK
SCARBOROUGH RM
NAUGHTON MA
HARKER LA
HANSON SR
Citation: Ak. Lindahl et al., ANTITHROMBOTIC EFFECT OF A THROMBIN RECEPTOR ANTAGONIST PEPTIDE IN BABOONS, Thrombosis and haemostasis, 69(6), 1993, pp. 1196-1196
Authors:
MARKOU C
LINDAHL AK
KU DN
GORECKI M
PINET A
GARFINKEL LI
HARKER LA
HANSON SR
Citation: C. Markou et al., SHEAR-DEPENDENT INHIBITION OF IN-VIVO THROMBUS FORMATION WITH A MONOMERIC VON-WILLEBRAND-FACTOR FRAGMENT, Thrombosis and haemostasis, 69(6), 1993, pp. 1241-1241
Authors:
LINDAHL AK
WILDGOOSE P
LUMSDEN AB
ALLEN R
KELLY AB
HARKER LA
HANSON SR
Citation: Ak. Lindahl et al., ACTIVE SITE-INHIBITED FACTOR-VIIA BLOCKS TISSUE FACTOR ACTIVITY AND PREVENTS ARTERIAL THROMBUS FORMATION IN BABOONS, Circulation, 88(4), 1993, pp. 417-417
Authors:
MARKOU C
LINDAHL AK
KELLY AB
KU DN
GORECKI M
PINET A
GARFINKEL LI
HARKER LA
HANSON SR
Citation: C. Markou et al., SHEAR-DEPENDENT ROLE OF GLYCOPROTEIN (GP) IB-VWF INTERACTION IN THE FORMATION OF THROMBUS IN-VIVO, Blood, 82(10), 1993, pp. 10000161-10000161
Risultati:
1-15
|